How can competition policy adapt to market changes caused by new technologies, digital platforms and big data companies?
How is global competition policy evolving given the challenges of the digital era?
A presentation of the EIB Investment Report
The 2018 Nobel Prize in Economic Sciences has been awarded jointly to William Nordhaus and Paul Romer for integrating respectively climate change and technological innovation into long-run macroeconomic analysis. We review how economists reacted to the announcement.
Bruegel senior fellow Scott Marcus welcomes former European Regulators Group chairman Kip Meek to explore the consequences of Brexit for ICT policy-making in Europe.
Testimony before the European Parliament's Committee on Industry, Research and Energy (ITRE).
As China shifts into a more advanced industrialised economy, Japan has slowly but surely lost to some of its comparative advantages to its rival. One possible solution to help the government keep pace would be to concentrate research and development efforts on a few key sectors where Japanese players still hold a large competitive lead.
How to measure China's digital economy?
The low-carbon technology sector is going through a period of disruptive innovation and strongly increased investment, which is likely to continue. Global investment in new renewable power is the largest area of electricity spending. The political momentum to combat climate change was reinforced in the Paris Agreement, when almost every country in the world agreed to aim for carbon neutrality in the second half of the century.
Technological development, and in particular digitalisation, has major implications for labour markets. Assessing its impact will be crucial for developing policies that promote efficient labour markets for the benefit of workers, employers and societies as a whole.
Testimony before the European Parliament Committee on the Internal Market and Consumer Protection (IMCO).
Analysis of the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as its economic effects.